Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

2000 • 15,583 citations

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

1999 • 2,565 citations

Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

2000 • 1,252 citations

Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma

1999 • 756 citations

Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

2006 • 597 citations

Sequential Biochemotherapy Versus Chemotherapy for Metastatic Melanoma: Results From a Phase III Randomized Trial

2002 • 378 citations

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

2000 • 346 citations

Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.

2000 • 331 citations

Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials

2003 • 323 citations

Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b

1999 • 318 citations

Chemotherapy and Targeted Therapy Combinations in Advanced Melanoma

2006 • 154 citations

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

2003 • 145 citations

Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials

1992 • 139 citations

Temozolomide in Combination With Interferon-Alfa Versus Temozolomide Alone in Patients With Advanced Metastatic Melanoma: A Randomized, Phase III, Multicenter Study from the Dermatologic Cooperative Oncology Group

2005 • 118 citations

Randomized Phase II Study of Temozolomide Given Every 8 Hours or Daily With Either Interferon Alfa-2b or Thalidomide in Metastatic Malignant Melanoma

2003 • 109 citations

Temozolomide plus thalidomide in patients with brain metastases from melanoma

2005 • 103 citations

Years of potential life lost: Another indicator of the impact of cutaneous malignant melanoma on society

1990 • 97 citations

Temozolomide Plus Thalidomide in Patients With Advanced Melanoma: Results of a Dose-Finding Trial

2002 • 68 citations

Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain

2006 • 62 citations

Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study.

1998 • 58 citations

Phase II study of thalidomide in patients with metastatic melanoma

2004 • 35 citations

Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)

2008 • 30 citations

A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma

2006 • 21 citations

A Pilot Trial of Combination Cisplatin, 5-Fluorouracil and Interferon-α in the Treatment of Advanced Esophageal Carcinoma

2002 • 20 citations

Thalidomide Enhances the Anti-Tumor Activity of Standard Chemotherapy in a Human Melanoma Xenotransplatation Model

2005 • 16 citations

High-Dose Platinum Combination Therapy in Pretreated Patients with Disseminated Melanoma

2007 • 13 citations